Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen.
about
Pharmacokinetic/pharmacodynamic modeling in inflammationPharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats.Pharmacokinetic strategies in deciphering atypical drug absorption profiles.Population pharmacokinetics of high dose ibuprofen in cystic fibrosis.Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation.Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.Modeling the onset and offset of dental pain relief by ibuprofen.Pharmacokinetics, pharmacodynamics and pharmacogenetics associated with nonsteroidal anti-inflammatory drugs and opioids in pediatric cancer patients.Explaining the acetaminophen-ibuprofen analgesic interaction using a response surface model.Pharmacologic, pharmacodynamic, and pharmacokinetic considerations with intravenous Ibuprofen lysine.PKPD model of interleukin-21 effects on thermoregulation in monkeys--application and evaluation of stochastic differential equations.Plasma and cerebrospinal fluid concentrations of ibuprofen in pediatric patients and antipyretic effect: Pharmacokinetic-pharmacodynamic modeling analysis.Modulation of oxidative and inflammatory cardiac response by nonselective 1- and 2-cyclooxygenase inhibitor and benznidazole in mice.
P2860
Q26830621-5D3DCA4F-E673-479D-8B66-55C893772A91Q33661085-D542E419-2962-459A-A248-4F8B4B3568A1Q35085676-068D45F6-3584-4324-8D70-B5ADB8DB9EEDQ35274875-35BE6D85-A757-45A7-A976-3C0152A5420CQ36125433-F45E0B0E-5CC5-4136-9718-9A40115101B6Q37361810-A1E2619B-AF52-4F2C-ADA2-7E1ADD3A02BAQ39269734-59B5647B-32EF-41F9-B01D-0528BFC55011Q39296300-9ADDD449-32D9-4228-B804-8077BB85A002Q39733241-03CE0CAA-8E20-437E-AFE3-1336F7360725Q40199090-6AAF8FB3-FAB4-44EF-A5BB-AE20011D0B75Q40468724-4F6A560A-F75D-4597-922A-7D3D2561F900Q43905536-446163C7-7828-47C3-9E84-87A75E757167Q46710618-1AC67796-4788-4FCD-953F-38C924AA4A49
P2860
Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Pharmacokinetic-Pharmacodynami ...... ral formulations of ibuprofen.
@en
type
label
Pharmacokinetic-Pharmacodynami ...... ral formulations of ibuprofen.
@en
prefLabel
Pharmacokinetic-Pharmacodynami ...... ral formulations of ibuprofen.
@en
P2093
P1476
Pharmacokinetic-Pharmacodynami ...... ral formulations of ibuprofen.
@en
P2093
Armenteros S
Domínguez R
Planelles MV
P304
P356
10.2165/00003088-200038060-00004
P577
2000-06-01T00:00:00Z
P5875
P6179
1049329019